Dermata Therapeutics (DRMA) News Today → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free DRMA Stock Alerts $0.36 +0.04 (+12.55%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDermata Therapeutics (NASDAQ:DRMA) Shares Up 1.7%americanbankingnews.com - May 2 at 3:24 AMDermata Therapeutics, Inc. (DRMAW)ca.finance.yahoo.com - February 11 at 3:44 PMPresenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Nowfinance.yahoo.com - February 6 at 7:49 AMDermata Therapeutics Inc DRMAmorningstar.com - February 4 at 12:48 PMDermata to Present at the Emerging Growth Conference on February 7, 2024finance.yahoo.com - February 1 at 10:31 AMDermata stock soars on patent issuance, partnership talksmsn.com - January 7 at 2:38 AMDow Turns Lower; ISM Services PMI Falls In Decembermsn.com - January 5 at 5:22 PMWhy Is Aesthetic Skin Conditions-Focused Dermata Therapeutics Stock Trading Higher Today?msn.com - January 5 at 12:22 PMWhy Is Dermata Therapeutics (DRMA) Stock Up 62% Today?investorplace.com - January 5 at 9:12 AMStocks to Watch: Dermata Therapeutics, Applied Therapeutics, Fusion Pharmaceuticalsmarketwatch.com - January 4 at 9:20 PMDermata Therapeutics Shares Surge 120% on Patent Issued in Japanmarketwatch.com - January 4 at 9:20 PMWhy Dermata Therapeutics Stock Took Off After-Hoursmsn.com - January 4 at 9:20 PMDermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosisfinance.yahoo.com - January 4 at 4:20 PMDermata Therapeutics: Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acnefinanznachrichten.de - December 21 at 1:59 PMDermata Therapeutics Stock (NASDAQ:DRMA) Dividends: History, Yield and Datesbenzinga.com - December 20 at 8:31 PMDermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acnefinance.yahoo.com - December 20 at 8:31 PMDermata Therapeutics Inc.thestreet.com - December 13 at 2:42 AMDermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - November 16 at 1:39 PMDermata to Begin Enrolling Patients in DMT310 Phase 3 Acne Clinical Program in December 2023 based on Agreement with FDA on the Phase 3 Protocolsfinance.yahoo.com - November 16 at 8:39 AMDermata Therapeutics GAAP EPS of -$0.54msn.com - November 10 at 10:22 AMDermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 9 at 5:47 PMDermata Therapeutics Completes Start-Up Activities to Support DMT310 Phase 3 STAR-1 Acne Trialfinance.yahoo.com - October 26 at 1:47 PMDermata to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - August 31 at 5:27 PMDermata Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 11 at 1:01 AMDermata Therapeutics Announces Positive Feedback from FDA on the DMT310 Phase 3 Clinical Development Program in Moderate-to-Severe Acnefinance.yahoo.com - June 27 at 9:05 AMDermata Therapeutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ETfinance.yahoo.com - June 13 at 4:57 PMJournal of the American Academy of Dermatology Publishes Positive DMT310 Phase 2b Acne Resultsfinance.yahoo.com - June 8 at 3:07 PMDermata Therapeutics: Journal of the American Academy of Dermatology Publishes Positive DMT310 Phase 2b Acne Resultsfinanznachrichten.de - June 8 at 10:07 AMDermata Therapeutics Announces Closing of $1.8 Million Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - May 26 at 4:37 PMDermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - May 24 at 10:06 AMDermata Therapeutics announces $1.8M offering priced ATMmsn.com - May 24 at 10:06 AMDermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - May 24 at 10:06 AMDermata Therapeutics Shares Rally Premarket on DMT310 Update >DRMAmarketwatch.com - May 12 at 10:32 AMDermata Therapeutics GAAP EPS of -$2.27seekingalpha.com - May 11 at 7:18 PMDermata Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 11 at 7:18 PMDermata Therapeutics awaits FDA go-ahead for lead candidate DMT310 to enter Phase 3 studiesproactiveinvestors.com - May 9 at 5:12 PMDermata (DRMA) Gains on Positive FDA Response for Acne Candidatefinance.yahoo.com - April 21 at 6:39 PMDermata Therapeutics: Dermata Announces Receipt of Type C Meeting Response from the FDA and Submission of DMT310 End of Phase 2 Meeting Packagefinanznachrichten.de - April 20 at 10:04 AMDermata climbs ~28% after update on acne candidatemsn.com - April 20 at 10:04 AMDermata Announces Receipt of Type C Meeting Response from the FDA and Submission of DMT310 End of Phase 2 Meeting Packagefinance.yahoo.com - April 20 at 10:04 AMDermata Therapeutics Inc (DRMA) has risen 6.40% Wednesday In Premarket Tradingbenzinga.com - March 31 at 8:01 AMDermata Therapeutics Stock (NASDAQ:DRMA), Guidance and Forecastbenzinga.com - March 26 at 3:24 PMWhy Is Allarity Therapeutics (ALLR) Stock Down 23% Today?markets.businessinsider.com - March 24 at 9:52 AMmarketbeat.com - March 23 at 2:56 PMDermata Therapeutics Announces Closing of $5.0 Million Public Offeringfinance.yahoo.com - March 20 at 8:39 PMDermata Therapeutics Announces Closing of $5.0 Million Public Offeringfinance.yahoo.com - March 20 at 8:39 PMDermata Therapeutics Up 24% After Boosting Size of Offeringmarketwatch.com - March 16 at 2:39 PMDermata Therapeutics Announces Pricing of $5.0 Million Public Offeringfinance.yahoo.com - March 16 at 2:39 PMDRMA Dermata Therapeutics, Inc.seekingalpha.com - February 28 at 4:38 AMDermata Therapeutics Provides Corporate Update and Reports Full Year 2022 Financial Resultsfinance.yahoo.com - February 21 at 6:59 PM Get Dermata Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DRMA and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide DRMA Media Mentions By Week DRMA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRMA News Sentiment▼1.890.56▲Average Medical News Sentiment DRMA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRMA Articles This Week▼10▲DRMA Articles Average Week Get Dermata Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DRMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SLRX News Today CNSP News Today CWBR News Today SXTP News Today SNOA News Today GLMD News Today BPTH News Today NTBL News Today CMND News Today ATXI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRMA) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.